Tofacitinib Helps in Ulcerative Colitis (CME/CE)
13:00 EDT 15 Aug 2012 | MedPageToday
(MedPage Today) -- The oral JAK inhibitor tofacitinib, currently under FDA review for treating rheumatoid arthritis, also showed promise for ulcerative colitis in a randomized trial.
Original Article: Tofacitinib Helps in Ulcerative Colitis (CME/CE)
More From BioPortfolio on "Tofacitinib Helps in Ulcerative Colitis (CME/CE)"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
